You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

biosimilarity

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022

Neutropenia Trial in Montevideo (Pegfilgastrim Megalabs, Pegfilgastim Amgen)

Recruiting
  • Neutropenia
  • Pegfilgastrim Megalabs
  • Pegfilgastim Amgen
  • Montevideo, Brazil
    Marcos Giusti
Apr 8, 2022

Healthy Trial (Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU, Active comparator Erythropoietin

Not yet recruiting
  • Healthy
  • Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU
  • Active comparator Erythropoietin Eprex® subcutaneous injection single dose of 4,000 IU
  • (no location specified)
Apr 8, 2022

Osteoporosis, Postmenopausal Trial (AVT03 (denosumab))

Recruiting
  • Osteoporosis, Postmenopausal
  • denosumab
  • Port Elizabeth, Gqeberha, South Africa
    PHOENIX Pharma(Pty)Ltd
Sep 1, 2022

Type 1 Diabetes, Type 2 Diabetes Trial in Bloemfontein (HEC-Glargine, US-Lantus)

Recruiting
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • Bloemfontein, Free State, South Africa
    FARMOVS Clinical Research Organization
Mar 28, 2022

Infertility, Female Trial in Cairo (Epifasi: Human chorionic gonadotrophin, Pregnyl: Human chorionic gonadotrophin)

Completed
  • Infertility, Female
  • Epifasi: Human chorionic gonadotrophin
  • Pregnyl: Human chorionic gonadotrophin
  • Cairo, Egypt
    Genuine Research Center GRC
Oct 22, 2020

Diabetes Trial in Mainz (Gan & Lee Insulin Lispro Injection)

Completed
  • Diabetes Mellitus
  • Gan & Lee Insulin Lispro Injection
  • Mainz, Germany
    Profil Mainz GmbH & Co. KG
Feb 11, 2020

Diabetes, Type 1 Trial in Mainz, Neuss (Gan & Lee Insulin Glargine Injection)

Completed
  • Diabetes Mellitus, Type 1
  • Gan & Lee Insulin Glargine Injection
  • Mainz, Germany
  • +1 more
Jan 17, 2020

Diabetes, Type 1 Trial in Mainz (Gan & Lee Insulin Aspart)

Completed
  • Diabetes Mellitus, Type 1
  • Gan & Lee Insulin Aspart
  • Mainz, Rhineland-Palatinate, Germany
    Profil Mainz GmbH & Co. KG
Feb 11, 2020

Natural Blood and Blood Product Toxicity Trial in Dhaka (Erythropoietin alpha)

Completed
  • Natural Blood and Blood Product Toxicity
  • Erythropoietin alpha
  • Dhaka, Bangladesh
  • +1 more
Oct 18, 2022

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Completed
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

Pharmacodynamics, Pharmacokinetics, Bioequivalence Trial in Yaroslavl (GP40141, Nplate)

Recruiting
  • Pharmacodynamics
  • +2 more
  • Yaroslavl, Russian Federation
    Yaroslavl Region "Clinical Hospital No. 3", ,, Mayakovskogo st.,
Dec 14, 2022

Type 2 Diabetes Trial in Zibo (14028 injection, dulaglutide injection)

Recruiting
  • Type 2 Diabetes
  • 14028 injection
  • dulaglutide injection
  • Zibo, Shandong, China
    PKUCare Luzhong Hospital
Jul 12, 2022

Healthy Trial in Zuidlaren (MYL-1402O, US marketed Avastin(R), EU marketed Avastin(R))

Completed
  • Healthy
  • Zuidlaren, Netherlands
    PRA Health Sciences - Early Development Services
Mar 9, 2022

Bone Metastases Trial in Beijing (MW032, Xgeva)

Active, not recruiting
  • Bone Metastases
  • Beijing, Beijing, China
    Fifth Medical Center of PLA General Hospital
Aug 31, 2021

Healthy Trial in Auckland NZ, Christchurch (BI 695502, bevacizumab)

Completed
Has Results
  • Healthy
  • Auckland NZ, New Zealand
  • +1 more
Oct 21, 2019

Healthy Subjects Trial in Shanghai (Ipilimumab, IBI310)

Recruiting
  • Healthy Subjects
  • Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Jun 21, 2021

Follicular Lymphoma Trial in United States (DRL_RI (Proposed rituximab biosimilar), MabThera®)

Active, not recruiting
  • Follicular Lymphoma
  • DRL_RI (Proposed rituximab biosimilar)
  • MabThera®
  • Whittier, California
  • +3 more
May 27, 2022

Breast Cancer Metastatic, Breast Cancer Female, Breast Cancer Recurrent Trial in Hanoi, Ho Chi Minh City (Faceptor, Herceptin,

Completed
  • Breast Cancer Metastatic
  • +2 more
  • Hanoi, Vietnam
  • +1 more
Mar 19, 2022

Renal Anaemia Trial in Bangkok (EPIAO®, EPREX®)

Terminated
  • Renal Anaemia
  • Bangkok, Thailand
  • +7 more
Oct 19, 2020

Breast Cancer Metastatic, Breast Cancer Recurrent, Breast Cancer Female Trial in Hanoi, Ho Chi Minh City (Faceptor, Herceptin,

Completed
  • Breast Cancer Metastatic
  • +2 more
  • Hanoi, Vietnam
  • +1 more
Mar 19, 2022

Bioequivalence, Healthy Trial in Turku (Interferon Beta-1A)

Completed
  • Bioequivalence
  • Healthy
  • Interferon Beta-1A
  • Turku, Finland
    CRST Oy, Clinical Research Services Turku Itäinen Pitkäkatu 4 B,
Jan 8, 2020

Anemia Trial (Epoetin Alfa 40000 UNT/ML)

Completed
Has Results
  • Anemia
  • Epoetin Alfa 40000 UNT/ML
  • (no location specified)
Feb 11, 2020

Lung Cancer, NSCLC Trial in Worldwide (Bevacizumab, SB8, Carboplatin)

Completed
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Brest, Belarus
  • +104 more
Jan 2, 2019